Y-mAbs Therapeutics Inc (YMAB)
11.56
-0.29
(-2.45%)
USD |
NASDAQ |
May 17, 16:00
11.56
0.00 (0.00%)
After-Hours: 20:00
Y-mAbs Therapeutics Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| June 30, 2022 | -0.526M |
| March 31, 2022 | -0.567M |
| December 31, 2021 | 61.04M |
| September 30, 2021 | 61.45M |
| June 30, 2021 | 58.81M |
| March 31, 2021 | 58.85M |
| December 31, 2020 | -2.785M |
| September 30, 2020 | -3.888M |
| Date | Value |
|---|---|
| June 30, 2020 | -1.792M |
| March 31, 2020 | -1.865M |
| December 31, 2019 | -1.965M |
| September 30, 2019 | -0.875M |
| June 30, 2019 | -0.311M |
| March 31, 2019 | -0.36M |
| December 31, 2018 | -0.234M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-3.888M
Minimum
Sep 2020
61.45M
Maximum
Sep 2021
17.35M
Average
-0.567M
Median
Mar 2022
Cash from Investing (TTM) Benchmarks
| The Cooper Companies Inc | -659.80M |
| Puma Biotechnology Inc | -20.76M |
| Humacyte Inc | 0.588M |
| NovaBay Pharmaceuticals Inc | 1.062M |
| Palatin Technologies Inc | 9.41M |